ENABLE: the first phase 4 observational study for patients with relapsing MS treated with ublituximab in real world clinical settings

Drug Category: Array
Conference Category: Array
Lead Author: Fox E, et. al
Published Date: 07/04/2025
Download Link: /wp-content/uploads/2025/09/ENABLE.AAN_2025.Poster.Fox-Final.pdf
Download Text:
Popup Confirmation?: 1
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top